Abstract
The following paper on the molecular biology of Barrett's esophagus (BE) includes commentaries on signaling pathways central to the development of BE including Hh, NF-κB, and IL-6/STAT3; surgical approaches for esophagectomy and classification of lesions by appropriate therapy; the debate over the merits of minimally invasive esophagectomy versus open surgery; outcomes for patients with pharyngolaryngoesophagectomy; the applications of neoadjuvant chemotherapy and chemoradiotherapy; animal models examining the surgical models of BE and esophageal adenocarcinoma; the roles of various morphogens and Cdx2 in BE; and the use of in vitro BE models for chemoprevention studies.
Original language | English |
---|---|
Pages (from-to) | 296-314 |
Number of pages | 19 |
Journal | Annals of the New York Academy of Sciences |
Volume | 1300 |
Issue number | 1 |
DOIs | |
Publication status | Published - Oct 2013 |
Externally published | Yes |
Keywords
- Barrett's esophagus
- Esophageal adenocarcinoma
- Esophagectomy
- MIE